- Home
- TIL vs OFS Comparison
TIL vs OFS Comparison
Compare TIL & OFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TIL | OFS |
|---|---|---|
| Founded | 2018 | 2001 |
| Country | United States | United States |
| Employees | N/A | 47 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.4M | 54.3M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | TIL | OFS |
|---|---|---|
| Price | $7.18 | $3.38 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $125.00 | N/A |
| AVG Volume (30 Days) | 10.3K | ★ 38.4K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 16.83% |
| EPS Growth | ★ 6.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.44 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.67 | $2.72 |
| 52 Week High | $33.83 | $8.99 |
Technical Indicators
Market Signals| Indicator | TIL | OFS |
|---|---|---|
| Relative Strength Index (RSI) | 37.32 | 44.87 |
| Support Level | $6.85 | $3.29 |
| Resistance Level | $8.30 | $4.01 |
| Average True Range (ATR) | 0.19 | 0.13 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 21.05 | 33.00 |
Price Performance
Historical ComparisonAbout TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About OFS OFS Capital Corporation
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to provide its stockholders with both current income and capital appreciation through debt investments and, to a lesser extent, equity investments.